3 completed, 1 active not recruiting. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Active not recruiting 1 |
Follow Meningococcal Immunisation: new trials by email Literature Review of Meningococcal Immunisation trials Research Report on Meningococcal Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers MenACYW conjugate vaccine - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 840 | 2024-03-19 | 2026-10-07 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1528 | 2023-03-27 | 2026-01-21 |
| Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 209 | 2022-08-23 | 2026-08-28 |
| Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine), Meningococcal group A, C, W-135, and Y conjugate vaccine, Human Papillomavirus 9-valent Vaccine (9vHPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 463 | 2021-03-16 | 2025-09-12 |
13-valent pneumococcal vaccine (1) · DTaP-IPV-HB-PRP-T vaccine (1) · Hepatitis A Vaccines (1) · Measles Vaccine (1) · Measles-Mumps-Rubella Vaccine (1) · Meningococcal Vaccines (1) · Poliovirus Vaccine, Inactivated (1) · Poliovirus Vaccines (1) · RotaTeq (1) · Rotavirus Vaccines (1) · Tetanus Toxoid (1) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1)
Sanofi Pasteur, a Sanofi Company (4)
Finland (2) · Germany (2) · Hungary (2) · Spain (2) · Czechia (1) · Denmark (1) · India (1) · Italy (1) · Poland (1) · Romania (1) · Singapore (1) · South Africa (1)
2023 (2)